![]() Internal applications, then our B2B based Bizapedia Pro API™ might be the answer for you. If you are looking for something more than a web based search utility and need to automate company and officer searches from within your WHAT'S INCLUDED IN THE ADVANCED SEARCH FORM? Hi friends I figured I would film a day in the life video for you guys while im here in New York for the summer. Utilize our advanced search form to filter the search results by Company Name, City, State, Postal Code, Filing Jurisdiction, Entity Type, Registered Agent,įile Number, Filing Status, and Business Category. While logged in and authenticated, you will not be asked to solve any complicated Recaptcha V2 challenges. In addition, all pages on Bizapedia will be served to you completely ad freeĪnd you will be granted access to view every profile in its entirety, even if the company chooses to hide the private information on their profile from the general public. This patent also provides for a diagnostic kit for identifying the type of venom from the animal bite and the severity of the bite.Īs a set these technologies have potential to make antivenom more accessible, easier to administer, and at a much lower cost than currently available antivenoms.Your entire office will be able to use your search subscription. Additionally, its antivenom production is stable in long-term storage in liquid form at ambient temperatures, a feature previously thought to be impossible for antivenom. The patented novel method results in an antivenom that has lower production cost, shorter synthesis time, and fewer adverse reactions than any previously known antivenom production method. Our patented technology presents improved methods for generating a universal antivenom, with breakthroughs in effectiveness, safety, manufacturing efficiency, and application. ![]() Approximately 400,000 people worldwide, with nearly 9,000 in the United States and Canada, are affected every year by snakebite envenomation. and other countries.Īs owner of the E140 patent and as an organization committed to promoting public health through proven solutions, Day Life Sciences seeks to work with funding entities (including non-profit, university, governmental, and private investment entities) to integrate the E140 technology into ongoing malaria vaccine research and development efforts.Īnimal envenomation is a major public health concern worldwide and is classified as a neglected disease by the World Health Organization. This research led to the issuance of an E140 patent in the U.S. The antigens can be utilized to induce an immune response and sterile protection against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other recombinant protein expression systems delivered as a vaccine formulation. Acquired by Welcome New York, New York, United States 11-50 Series C Private 227,437 Highlights Total Funding Amount 15. This invention provides polypeptides useful as antigens expressed at the pre-erythrocytic stage of the malaria parasite. Daylife is a cloud-based media platform offering digital media management tools and content feeds to publishers and brand marketers. Government: Navy Medical Research Center, Army Walter Reed Army Institute of Research, Bill and Melinda Gates Foundation, CAMRIS International, and others. ![]() Research to date has been supported by the U.S. An extremely promising breakthrough was made by a laboratory antigen discovery research team, that showed an effectiveness level of up to 99% for vaccine delivery coupled with the E140 antigen.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |